⌘K

Home/Filings/4/0000930413-11-007260

4//SEC Filing

Buchbinder Aby 4

Accession 0000930413-11-007260

CIK 0000727510other

View on SEC.gov Company Profile

Filed

Nov 9, 7:00 PM ET

Accepted

Nov 10, 5:05 PM ET

Size

4.8 KB

Accession

0000930413-11-007260

Insider Transaction Report

Form 4

Period: 2011-11-08

ENZON PHARMACEUTICALS INCENZN

VP, Clinical Development

Transactions

Sale
Common Stock
2011-11-08$7.06/sh−2,700$19,062→ 54,015 total

Documents

1 file

4
c67539_4.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

ENZON PHARMACEUTICALS INC

CIK 0000727510

Entity typeother

Related Parties

1

filerCIK 0001526633

Filing Metadata

Form type: 4
Filed: Nov 9, 7:00 PM ET
Accepted: Nov 10, 5:05 PM ET
Size: 4.8 KB

View on SEC.gov